Inventor
KOVACH JOHN S
US30 patents
⚠️ This page may combine multiple inventors who share the name “KOVACH JOHN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIXTE BIOTECHNOLOGY INC
17 patentsUS7998957B2Aug 16, 2011
Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use
LIXTE BIOTECHNOLOGY INC39 citations96
US9079917B2Jul 14, 2015
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
LIXTE BIOTECHNOLOGY INC17 citations92
US8822461B2Sep 2, 2014
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
LIXTE BIOTECHNOLOGY INC16 citations92
US10399993B2Sep 3, 2019
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
LIXTE BIOTECHNOLOGY INC5 citations84
US10149847B2Dec 11, 2018
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
LIXTE BIOTECHNOLOGY INC6 citations84
US10023587B2Jul 17, 2018
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
LIXTE BIOTECHNOLOGY INC6 citations84
US11236102B2Feb 1, 2022
Oxabicycloheptane prodrugs
LIXTE BIOTECHNOLOGY INC5 citations83
US10618908B2Apr 14, 2020
Oxabicycloheptane prodrugs
LIXTE BIOTECHNOLOGY INC6 citations83
US10364252B2Jul 30, 2019
Oxabicycloheptane prodrugs
LIXTE BIOTECHNOLOGY INC7 citations83
US9988394B2Jun 5, 2018
Oxabicycloheptane prodrugs
LIXTE BIOTECHNOLOGY INC7 citations83
US10532050B2Jan 14, 2020
Formulations of oxabicycloheptanes and oxabicycloheptenes
LIXTE BIOTECHNOLOGY INC5 citations80
US11866444B2Jan 9, 2024
Oxabicycloheptane prodrugs
LIXTE BIOTECHNOLOGY INC1 citations73
US10668062B2Jun 2, 2020
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
LIXTE BIOTECHNOLOGY INC5 citations73
US11931354B2Mar 19, 2024
Formulations of oxabicycloheptanes and oxabicycloheptenes
LIXTE BIOTECHNOLOGY INC1 citations69
US10413541B2Sep 17, 2019
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
LIXTE BIOTECHNOLOGY INC5 citations67
US12343342B2Jul 1, 2025
Methods for treating soft tissue sarcoma
LIXTE BIOTECHNOLOGY INC0 citations58
US12168008B2Dec 17, 2024
Oxabicycloheptanes for modulation of immune response
LIXTE BIOTECHNOLOGY INC0 citations50
KOVACH JOHN S
8 patentsUS8058268B2Nov 15, 2011
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
KOVACH JOHN S46 citations97
US8541458B2Sep 24, 2013
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
KOVACH JOHN S17 citations92
US8329719B2Dec 11, 2012
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
KOVACH JOHN S16 citations92
US8227473B2Jul 24, 2012
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
KOVACH JOHN S26 citations92
US8143445B2Mar 27, 2012
HDAC inhibitors
KOVACH JOHN S22 citations92
US9526915B2Dec 27, 2016
Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
KOVACH JOHN S15 citations84
US8455688B2Jun 4, 2013
HDAC inhibitors
KOVACH JOHN S14 citations84
US9833450B2Dec 5, 2017
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
KOVACH JOHN S9 citations78